PEDRO LICHTINGER

Profile

First Name

: PEDRO

Middle Name

:

Last Name

: LICHTINGER

Related Companies
Titles
Company Name
Related People
DIRECTOR
VELCERA, INC.
R SCOTT BARRY, JOSHUA A KAZAM, MICHAEL MASHAAL, JOHN MICHAEL PRESTON, DENNIS F STEADMAN, SAL J UGLIETTA
DIRECTOR
BIOTIME INC
FRANKLIN M. BERGER, NEAL C BRADSHER, ARNOLD I BURNS, ROBERT N BUTLER, ABRAHAM E COHEN, STEPHEN C. FARRELL, WALTER FUNK, VALETA GREGG, VALETA A GREGG, ALFRED D KINGSLEY, HENRY L. NORDHOFF, ROBERT W PEABODY, JUDITH SEGALL, STEVEN A SEINBERG, HAL STERNBERG, WILLIAM P. TEW, GREGG VALETA, ANDREW C. VON ESCHENBACH, HAROLD WAITZ, MICHAEL D WEST
EXECUTIVE OFFICER, DIRECTOR
ASTERIAS BIOTHERAPEUTICS, INC.
ANDREW ARNO, ALFRED D KINGSLEY, JANE S LEBKOWSKI, RICHARD T LEBUHN, RICHARD T. LEBUHN, ROBERT W PEABODY, NATALE RICCIARDI, JUDITH SEGALL, KATHARINE SPINK, MICHAEL D WEST
DIRECTOR
GEMPHIRE THERAPEUTICS INC.
AKASH BAKSHI, ANDREW BARTYNSKI, CHARLES BISGAIER, MARK A. GLICKMAN, LEE S. GOLDEN, JASON GROVES, JASON L. GROVES, STEVE GULLANS, STEPHEN HAAKENSON, P. KENT HAWRYLUK, RICHARD J. KANG, HYUNG HEON KIM, NA YEON KIM, KENNETH KOUSKY, ANDREW KOVEN, ANDREW I KOVEN, DAVID LOWENSCHUSS, NADJA MANNOWETZ, JEFFREY MATHIESEN, MARGARET MCSHANE, JEONG GYUN OH, DANIELA ONICIU, SETH RENO, MICHAEL SALSBURY, ANDY SASSINE, NICOLA SHANNON, MINA SOOCH, D. GORDON STRICKLAND, DOUGLAS J. SWIRSKY, JAMES P. TURSI, MARSHALL H. WOODWORTH, AMY ZAREMBA RABOURN
EXECUTIVE OFFICER, DIRECTOR
CHEMIOCARE INC.
KENNETH ANDERSON, ERIC BAUM, ASHER CHANAN-KHAN, KEITH DARRAGH, MOSES DODO, MOHAMAD HUSSEIN, SCOTT KAHN, NINTIN KAUSHAL, NITIN KAUSHAL, PEDRO LICHTINGER WAISMAN, JAMIE OLIVER, LITSA PERPERIDIS, FOTIOS PLAKOGIANNIS, ROMAN ROGOL, CIDNEE VAYKOVICH, PEDRO WAISMAN, ROY WALDON, ROY WALDRON
EXECUTIVE OFFICER, DIRECTOR
STARTON THERAPEUTICS INC.
KENNETH ANDERSON, ERIC BAUM, ASHER CHANAN-KHAN, KEITH DARRAGH, MOSES DODO, MOHAMAD HUSSEIN, SCOTT KAHN, NINTIN KAUSHAL, NITIN KAUSHAL, PEDRO LICHTINGER WAISMAN, JAMIE OLIVER, LITSA PERPERIDIS, FOTIOS PLAKOGIANNIS, ROMAN ROGOL, CIDNEE VAYKOVICH, PEDRO WAISMAN, ROY WALDON, ROY WALDRON
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-05-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-03 
2020-01-13
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-20 
2018-07-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-04 
2017-03-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-03-15 
2016-04-27
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2015-07-31 
2016-03-10
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2015-07-31 
2015-12-22
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2015-07-31 
2015-02-23
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-02-09 
2014-06-20
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
 
2014-06-16 
2014-06-19
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Equity 
2014-06-09 
2014-03-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2014-03-04 
2011-03-24
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2011-03-21 
2011-02-02
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2011-01-28 
2010-12-07
D/A
Link
OTHER 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2010-06-07 
2010-06-21
D
Link
OTHER 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2010-06-07 
2010-05-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2010-05-07 
2010-05-05
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2010-04-27